• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诱导化疗后(放)化疗与单纯放化疗或基于手术的治疗在局部晚期 III/IV 期下咽癌中的长期肿瘤学和功能结局:266 例多中心回顾。

Long-term oncological and functional outcomes of induction chemotherapy followed by (chemo)radiotherapy vs definitive chemoradiotherapy vs surgery-based therapy in locally advanced stage III/IV hypopharyngeal cancer: Multicenter review of 266 cases.

机构信息

Department of Otorhinolaryngology - Head and Neck Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.

Department of Otorhinolaryngology - Head and Neck Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea.

出版信息

Oral Oncol. 2019 Feb;89:84-94. doi: 10.1016/j.oraloncology.2018.12.015. Epub 2018 Dec 27.

DOI:10.1016/j.oraloncology.2018.12.015
PMID:30732965
Abstract

OBJECTIVE

The aim of this study was to evaluate the treatment outcomes for stage III/IV locally advanced hypopharyngeal squamous cell carcinoma (SCC), comparing induction chemotherapy followed by (chemo)radiotherapy (ICT), definitive chemoradiotherapy (CRT) and surgery-based therapy (SRT).

SUBJECTS AND METHODS

Two hundred sixty-six patients with stage III/IV locally advanced hypopharyngeal squamous cell carcinoma (SCC) who underwent ICT (n = 74), CRT (n = 53) or SRT (n = 139) from 1997 through 2014 at the Seoul National University Hospital (n = 127) and the Hallym University Medical Center (n = 139) were enrolled in the study. All surgical procedures in the SRT group were performed by a single surgeon to eliminate surgeon bias.

RESULTS

The 5-year disease-free survival (DFS) and overall survival (OS) of all patients (n = 266) were 59.4% and 44%, respectively. The 5-year DFS rates after salvage treatment were 52.7% for ICT, 52.8% for CRT and 65.5% for SRT (p = 0.194). The OS rates were 44.6% for ICT, 39.6% for CRT and 45.3% for SRT group (p = 0.106). The salvage rates were 12.5% for ICT, 15.6% for CRT and 3.8% for SRT group. The final laryngeal preservation rate was significantly lower in the SRT group (44.6%) than in the ICT (71.6%) or CRT (71.7%) groups. All major postoperative complications were significantly higher in the salvage surgery group.

CONCLUSION

Treatment outcomes in the ICT and CRT groups were comparable to that of the SRT group for stage III/IV hypopharyngeal SCC. However, the relatively low chance of cure and high risk of complications should be taken into account when considering salvage surgery.

摘要

目的

本研究旨在评估 III/IV 期局部晚期下咽鳞状细胞癌(SCC)的治疗结果,比较诱导化疗后(放)化疗(ICT)、根治性放化疗(CRT)和基于手术的治疗(SRT)。

对象和方法

1997 年至 2014 年间,首尔国立大学医院(n=127)和翰林大学医疗中心(n=139)共招募了 266 名接受 ICT(n=74)、CRT(n=53)或 SRT(n=139)的 III/IV 期局部晚期下咽鳞状细胞癌(SCC)患者。所有 SRT 组的手术均由一名外科医生进行,以消除外科医生的偏见。

结果

所有患者(n=266)的 5 年无病生存率(DFS)和总生存率(OS)分别为 59.4%和 44%。ICT、CRT 和 SRT 组的挽救性治疗后 5 年 DFS 率分别为 52.7%、52.8%和 65.5%(p=0.194)。ICT、CRT 和 SRT 组的 OS 率分别为 44.6%、39.6%和 45.3%(p=0.106)。ICT、CRT 和 SRT 组的挽救率分别为 12.5%、15.6%和 3.8%。SRT 组最终保喉率明显低于 ICT(71.6%)或 CRT(71.7%)组(44.6%)。所有主要术后并发症在挽救手术组中明显更高。

结论

对于 III/IV 期下咽 SCC,ICT 和 CRT 组的治疗结果与 SRT 组相当。然而,在考虑挽救性手术时,应考虑到治愈机会相对较低和并发症风险较高的问题。

相似文献

1
Long-term oncological and functional outcomes of induction chemotherapy followed by (chemo)radiotherapy vs definitive chemoradiotherapy vs surgery-based therapy in locally advanced stage III/IV hypopharyngeal cancer: Multicenter review of 266 cases.诱导化疗后(放)化疗与单纯放化疗或基于手术的治疗在局部晚期 III/IV 期下咽癌中的长期肿瘤学和功能结局:266 例多中心回顾。
Oral Oncol. 2019 Feb;89:84-94. doi: 10.1016/j.oraloncology.2018.12.015. Epub 2018 Dec 27.
2
Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer.可切除的Ⅲ/Ⅳ期下咽癌:根治性放化疗与手术加辅助放疗的比较
Cancer Res Treat. 2016 Jan;48(1):45-53. doi: 10.4143/crt.2014.340. Epub 2015 Mar 13.
3
[A retrospective study on combined modality therapy with or without surgery for advanced hypopharyngeal squamous cell carcinoma: an analysis of 119 cases].[晚期下咽鳞状细胞癌手术联合或不联合综合治疗的回顾性研究:119例分析]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 May 7;53(5):352-358. doi: 10.3760/cma.j.issn.1673-0860.2018.05.005.
4
Can response to induction chemotherapy be a predictive marker for ultimate outcome in hypopharyngeal cancer?诱导化疗的反应能否成为下咽癌最终结局的预测标志物?
Otolaryngol Head Neck Surg. 2012 Jan;146(1):74-80. doi: 10.1177/0194599811420357. Epub 2011 Sep 6.
5
Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience.鼻咽癌诱导化疗的临床病理特征和疗效:真实世界经验。
Oncol Res Treat. 2024;47(7-8):360-367. doi: 10.1159/000537988. Epub 2024 Apr 2.
6
[Comparative analysis of clinical efficacies between induction chemotherapy and surgery combined with radiotherapy or concurrent chemoradiotherapy in advanced hypopharyngeal carcinoma].[诱导化疗与手术联合放疗或同步放化疗治疗晚期下咽癌的临床疗效对比分析]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Dec 7;53(12):918-924. doi: 10.3760/cma.j.issn.1673-0860.2018.12.009.
7
Concurrent chemoradiotherapy improves survival in patients with hypopharyngeal cancer.同期放化疗可改善下咽癌患者的生存。
Int J Radiat Oncol Biol Phys. 2012 Mar 15;82(4):1515-21. doi: 10.1016/j.ijrobp.2011.04.064. Epub 2011 Jun 12.
8
[Meta-analysis of comparison for efficacies between surgical plus radio(chemo)therapy and non-surgery chemoradiotherapy treatment strategies for advanced hypopharyngeal cancer].[手术联合放(化)疗与非手术放化疗治疗晚期下咽癌疗效比较的Meta分析]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2020 Feb 7;55(2):144-149. doi: 10.3760/cma.j.issn.1673-0860.2020.02.011.
9
Long-term outcomes of induction chemotherapy followed by chemoradiotherapy using volumetric-modulated arc therapy as an organ preservation approach in patients with stage IVA-B oropharyngeal or hypopharyngeal cancers.诱导化疗后行容积旋转调强放疗治疗IVA-B 期口咽或下咽鳞癌的器官保留疗效观察
J Radiat Res. 2020 Jul 6;61(4):554-562. doi: 10.1093/jrr/rraa033.
10
Chemoradiotherapy versus surgery followed by postoperative radiotherapy in tonsil cancer: Korean Radiation Oncology Group (KROG) study.化疗联合放疗对比手术联合术后放疗治疗扁桃体癌:韩国放射肿瘤学会研究
BMC Cancer. 2017 Aug 30;17(1):598. doi: 10.1186/s12885-017-3571-3.

引用本文的文献

1
The clinical outcomes of induction chemotherapy followed by radiotherapy vs. chemoradiotherapy in locally advanced hypopharyngeal squamous cell carcinoma: A retrospective study.诱导化疗后放疗与同步放化疗治疗局部晚期下咽鳞状细胞癌的临床疗效:一项回顾性研究。
Heliyon. 2024 Oct 1;10(20):e38811. doi: 10.1016/j.heliyon.2024.e38811. eCollection 2024 Oct 30.
2
Upfront Surgery Versus Upfront Concurrent Chemoradiotherapy as Primary Modality in Hypopharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis. upfront 手术与 upfront 同期放化疗作为下咽鳞癌的主要治疗方式:系统评价和荟萃分析。
J Otolaryngol Head Neck Surg. 2024 Jan-Dec;53:19160216241293633. doi: 10.1177/19160216241293633.
3
Efficacy of PD-1 inhibitor with neoadjuvant chemotherapy in hypopharyngeal and oropharyngeal cancer.
PD-1抑制剂联合新辅助化疗治疗下咽癌和口咽癌的疗效
Front Oncol. 2024 Sep 24;14:1450830. doi: 10.3389/fonc.2024.1450830. eCollection 2024.
4
Modified traditional TNM staging of pyriform sinus and hypopharyngeal and laryngeal cancer based on lymph node ratio and its clinical significance: a population-based study combined with external validation.基于淋巴结比率的梨状窦、下咽及喉癌改良传统TNM分期及其临床意义:一项基于人群的研究并结合外部验证
Int J Surg. 2025 Jan 1;111(1):737-750. doi: 10.1097/JS9.0000000000001851.
5
Oncological Outcomes of Concurrent Chemoradiotherapy and Surgical Treatment for Patients With T3 Hypopharyngeal Cancer: A Single-Center Retrospective Analysis.T3期下咽癌患者同步放化疗与手术治疗的肿瘤学结局:单中心回顾性分析
Cureus. 2024 Jun 17;16(6):e62553. doi: 10.7759/cureus.62553. eCollection 2024 Jun.
6
Algorithms of follow-up in patients with head and neck cancer in relation to primary location and advancement. Consensus of Polish ENT Society Board and Head Neck Experts.与原发部位和进展相关的头颈癌患者随访算法。波兰耳鼻喉科学会理事会和头颈专家共识。
Front Oncol. 2023 Dec 12;13:1298541. doi: 10.3389/fonc.2023.1298541. eCollection 2023.
7
Results of salvage neck dissection after chemoradiation in locally advanced head and neck squamous cell carcinoma.局部晚期头颈部鳞状细胞癌放化疗后挽救性颈清扫术的结果。
Eur Arch Otorhinolaryngol. 2024 Feb;281(2):945-951. doi: 10.1007/s00405-023-08315-z. Epub 2023 Oct 28.
8
ALKBH5 promotes hypopharyngeal squamous cell carcinoma apoptosis by targeting TLR2 in a YTHDF1/IGF2BP2-mediated manner.ALKBH5通过YTHDF1/IGF2BP2介导的方式靶向TLR2促进下咽鳞状细胞癌凋亡。
Cell Death Discov. 2023 Aug 23;9(1):308. doi: 10.1038/s41420-023-01589-6.
9
Primary tracheobronchial necrosis after esophagectomy: A nationwide multicenter retrospective study in Japan.食管癌切除术后原发性气管支气管坏死:日本全国多中心回顾性研究
Ann Gastroenterol Surg. 2022 Oct 8;7(2):236-246. doi: 10.1002/ags3.12625. eCollection 2023 Mar.
10
Survival analyses of different treatment modalities and clinical stage for hypopharyngeal carcinoma.下咽癌不同治疗方式及临床分期的生存分析
Front Oncol. 2023 Mar 3;13:1109417. doi: 10.3389/fonc.2023.1109417. eCollection 2023.